Literature DB >> 30042147

The case against catheter-directed thrombolysis in patients with proximal deep vein thrombosis.

Jacqueline N Poston1, David A Garcia1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30042147      PMCID： PMC6058231          DOI： 10.1182/bloodadvances.2018018630

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  9 in total

Review 1.  Scoring systems for the post-thrombotic syndrome.

Authors:  Arany Soosainathan; Hayley M Moore; Manjit S Gohel; Alun H Davies
Journal:  J Vasc Surg       Date:  2012-11-20       Impact factor: 4.268

2.  Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence.

Authors:  G Palareti; C Legnani; B Cosmi; G Guazzaloca; M Cini; S Mattarozzi
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

3.  Comparative outcomes of catheter-directed thrombolysis plus anticoagulation vs anticoagulation alone to treat lower-extremity proximal deep vein thrombosis.

Authors:  Riyaz Bashir; Chad J Zack; Huaqing Zhao; Anthony J Comerota; Alfred A Bove
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

4.  Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial.

Authors:  Susan R Kahn; Stan Shapiro; Philip S Wells; Marc A Rodger; Michael J Kovacs; David R Anderson; Vicky Tagalakis; Adrielle H Houweling; Thierry Ducruet; Christina Holcroft; Mira Johri; Susan Solymoss; Marie-José Miron; Erik Yeo; Reginald Smith; Sam Schulman; Jeannine Kassis; Clive Kearon; Isabelle Chagnon; Turnly Wong; Christine Demers; Rajendar Hanmiah; Scott Kaatz; Rita Selby; Suman Rathbun; Sylvie Desmarais; Lucie Opatrny; Thomas L Ortel; Jeffrey S Ginsberg
Journal:  Lancet       Date:  2013-12-06       Impact factor: 79.321

5.  Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial.

Authors:  Ylva Haig; Tone Enden; Ole Grøtta; Nils-Einar Kløw; Carl-Erik Slagsvold; Waleed Ghanima; Leiv Sandvik; Geir Hafsahl; Pål Andre Holme; Lars Olaf Holmen; Anne Mette Njaaastad; Gunnar Sandbæk; Per Morten Sandset
Journal:  Lancet Haematol       Date:  2016-01-06       Impact factor: 18.959

6.  Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.

Authors:  Tone Enden; Ylva Haig; Nils-Einar Kløw; Carl-Erik Slagsvold; Leiv Sandvik; Waleed Ghanima; Geir Hafsahl; Pål Andre Holme; Lars Olaf Holmen; Anne Mette Njaastad; Gunnar Sandbæk; Per Morten Sandset
Journal:  Lancet       Date:  2011-12-13       Impact factor: 79.321

7.  Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial.

Authors:  Arina J Ten Cate-Hoek; Elham E Amin; Annemieke C Bouman; Karina Meijer; Lidwine W Tick; Saskia Middeldorp; Guy J M Mostard; Marije Ten Wolde; Simone M van den Heiligenberg; Sanne van Wissen; Marlène Hw van de Poel; Sabina Villalta; Erik H Serné; Hans-Martin Otten; Edith H Klappe; Ingrid M Bistervels; Mandy N Lauw; Margriet Piersma-Wichers; Paolo Prandoni; Manuela A Joore; Martin H Prins; Hugo Ten Cate
Journal:  Lancet Haematol       Date:  2017-12-05       Impact factor: 18.959

8.  Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis.

Authors:  T Enden; S Resch; C White; H S Wik; N E Kløw; P M Sandset
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

9.  Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.

Authors:  Suresh Vedantham; Samuel Z Goldhaber; Jim A Julian; Susan R Kahn; Michael R Jaff; David J Cohen; Elizabeth Magnuson; Mahmood K Razavi; Anthony J Comerota; Heather L Gornik; Timothy P Murphy; Lawrence Lewis; James R Duncan; Patricia Nieters; Mary C Derfler; Marc Filion; Chu-Shu Gu; Stephen Kee; Joseph Schneider; Nael Saad; Morey Blinder; Stephan Moll; David Sacks; Judith Lin; John Rundback; Mark Garcia; Rahul Razdan; Eric VanderWoude; Vasco Marques; Clive Kearon
Journal:  N Engl J Med       Date:  2017-12-07       Impact factor: 176.079
  9 in total
  1 in total

1.  Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb.

Authors:  Cathryn Broderick; Lorna Watson; Matthew P Armon
Journal:  Cochrane Database Syst Rev       Date:  2021-01-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.